Whan In Pharm Co.,Ltd.
Research Whan In Pharm Co.,Ltd. (016580.KS) on Bullrun: market cap KRW 192.05B, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker016580.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 192.05B
- Dividend yield2.8%
- Financial periodQ2 2026
- RevenueKRW 71.42B
- Net incomeKRW 7.70B
- Free cash flowKRW 8.25B
- Gross margin38.9%
Valuation Snapshot
latest market cap is KRW 192.05B; dividend yield is 2.8%.
Peer valuation comparison
Latest dividend yield is 2.8% versus a Healthcare sector median of 2.4% (16.7% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 192.05B | n/a | 2.9% | 300 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 300 KRW, yield 2.8%.
About Whan In Pharm Co.,Ltd.
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use...
ETFs that hold Whan In Pharm Co.,Ltd.
US-listed ETFs
Whan In Pharm Co.,Ltd. is held by 4 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Whan In Pharm Co.,Ltd.'s market cap?
Whan In Pharm Co.,Ltd.'s market capitalization is KRW 192.05B.
Does Whan In Pharm Co.,Ltd. pay a dividend?
Whan In Pharm Co.,Ltd. has a dividend yield of 2.8%.
What does Whan In Pharm Co.,Ltd. do?
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and.